Immunotherapy for Head and Neck Cancer Treatment

0 Views
administrator
administrator
07/02/23

Head and neck cancer and skull base surgeon Nyall London discusses immunotherapy clinical trials that have contributed to FDA approval for nivolumab and pembrolizumab for recurrent head and neck squamous cell carcinoma. https://hopkinsmedicine.org/oto #HeadandNeckCancerTreatment #JohnsHopkins

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next